Biotech Stocks


PhaseRx Inc (PZRX) Stock Rallies on Investor Optimism Over Orphan Drug Designation in the European Union

Can you feel the ground moving beneath your feet? Shares of PhaseRx Inc (NASDAQ:PZRX) skyrocket over 70% today, after the drug maker announced …

Here’s What Triggered Auris Medical Holding AG (EARS) Selloff

Auris Medical Holding AG (NASDAQ:EARS) investors hit the panic button following the news that the hearing device maker is discontinuing development of AM-111 …

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Keeps This Bull Enthusiastic as CEO Kare Schultz Strides Towards Leaner Operating Structure

Teva has stirred up Street excitement with news of executive changes and an organizational overhaul.

Teva’s Leader CEO Kare Schultz Is Playing the Restructuring Card; Louise Chen Welcomes These “Winds of Change”

Here’s what Cantor’s Louise Chen has to say about the recent developments at Teva’s headquarters.

Quant King David Shaw Pours More Money Into Valeant Pharmaceuticals Intl Inc (VRX), MannKind Corporation (MNKD)

One of the world’s top fund managers is backing volatile healthcare stocks VRX and MNKD.

Should You Gamble on Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and TherapeuticsMD Inc (TXMD)? Benjamin Smith’s Hedge Fund Did

Billion-dollar Laurion fund initiates new positions in TEVA and TXMD.

The Good and the Ugly Side of Biotech: Celsion Corporation (CLSN), Cytokinetics, Inc. (CYTK)

The Good: Oppenheimer Sees Celsion Corporation Shares Soaring About 180% Over 12 Months It can be tricky putting a price tag on a …

Cytokinetics, Inc. (CYTK) Has Not Lost This Bull in the Wake of Phase III Failure

Look out for the Street’s bearish stampede today where CYTK shares are crashing 31% in the aftermath of lead drug tirasemtiv’s failure.

Cytokinetics, Inc. (CYTK) Stock Gets Whacked on Disappointing Clinical Results in ALS

Cytokinetics, Inc. (NASDAQ:CYTK) investors hit the panic button following the news that the drug makerĀ is discontinuing development of tirasemtiv for amyotrophic lateral sclerosis …

Celsion Corporation (CLSN) Stock Fires to the Roof on Back of New Bull’s Confident Bet

Oppenheimer’s Hartaj Singh sees 227% upside potential for CLSN.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts